ClassID:

94778

C07D277/68 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems; Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Sub-classes:
Recent Application in this class:
#1
20250320186
2025-10-16

HSD17B13 INHIBITORS AND USES THEREOF

#2
20250296935
2025-09-25

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

#3
20250257065
2025-08-14

SMALL MOLECULE PYRIN-DOMAIN TARGETED NLRP3 INFLAMMASOME INHIBITORS

#4
20250197413
2025-06-19

RXFP1 RECEPTOR AGONISTS

#5
20250179028
2025-06-05

ACRYLAMIDE COMPOUNDS

#6
20250144078
2025-05-08

THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF

#7
20250066290
2025-02-27

DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE

#8
20250011293
2025-01-09

LEUKOTRIENE SYNTHESIS INHIBITORS

#9
20240360083
2024-10-31

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#10
20240317704
2024-09-26

PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE

#11
20240294482
2024-09-05

METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR

#12
20240270701
2024-08-15

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

#13
20240067614
2024-02-29

NOVEL COMPOUNDS

#14
20230373938
2023-11-23

BENZOTHIAZOLE MEROTERPENOID COMPOUND AND DERIVATIVE THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#15
20230295095
2023-09-21

NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF

#16
20230250104
2023-08-10

Diamine derivatives as inhibitors of leukotriene Ahydrolase

#17
20230106144
2023-04-06

Compounds and methods for detection of superoxide

#18
20230047589
2023-02-16

INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY

#19
20220324822
2022-10-13

BENAZOLIN-CHOLINE AND ITS USE IN THE AGROCHEMICAL FIELD

#20
20220315534
2022-10-06

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

#21
20220304984
2022-09-29

AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF

#22
20220220068
2022-07-14

FUNGICIDAL ARYL AMIDINES

#23
20220098188
2022-03-31

Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors

#24
20220064132
2022-03-03

Leukotriene synthesis inhibitors

#25
20210198206
2021-07-01

Therapeutic compounds and compositions

#26
20210130301
2021-05-06

Compositions for the treatment of pulmonary fibrosis

#27
20210122710
2021-04-29

Phenylamine compounds

#28
20210070720
2021-03-11

Luminescent compounds

#29
20200331902
2020-10-22

Derivatives of luciferin and methods for their synthesis

#30
20200308181
2020-10-01

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#31
20200183279
2020-06-11

PHOTOSENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE

#32
20190345109
2019-11-14

Therapeutic compounds and compositions

#33
20190308945
2019-10-10

Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors

#34
20190290784
2019-09-26

LUCIFERIN DERIVATIVES FROM BICYCLIC REACTANTS AND AMINOTHIOL DERIVATIVES AND METHODS OF USE THEREOF

#35
20190270712
2019-09-05

Compositions for the treatment of pulmonary fibrosis

#36
20190241523
2019-08-08

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#37
20190177310
2019-06-13

Inhibitors of integrated stress response pathway

#38
20190092735
2019-03-28

Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators

#39
20190046511
2019-02-14

Endoparasite control agent

#40
20190031629
2019-01-31

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

#41
20180251434
2018-09-06

ANTIBACTERIAL HETEROCYCLIC DERIVATIVES

#42
20180230159
2018-08-16

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#43
20180140582
2018-05-24

Benzothiazolone compound

#44
20180127388
2018-05-10

THERAPEUTIC COMPOUNDS

#45
20180007907
2018-01-11

Pesticidally active semi-carbazones and thiosemicarbazones derivatives

#46
20170335368
2017-11-23

Luciferin-containing substrate and monitoring device including the substrate

#47
20170319516
2017-11-09

Mitochondrial uncouplers for treatment of metabolic diseases and cancer

#48
20170313713
2017-11-02

Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors

#49
20170044100
2017-02-16

INHIBITORS OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS

#50
20170036969
2017-02-09

NITRIFICATION INHIBITORS

#51
20170001998
2017-01-05

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#52
20160297767
2016-10-13

Estrogen receptor modulators and uses thereof

#53
20160280671
2016-09-29

Compositions for the treatment of hypertension and/or fibrosis

#54
20160279107
2016-09-29

Benzothiazolone compound

#55
20160272649
2016-09-22

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#56
20160259242
2016-09-08

Onium salt compound, resist composition, and pattern forming process

#57
20160257641
2016-09-08

Alkylene derivatives

#58
20160176830
2016-06-23

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

#59
20160152582
2016-06-02

THERAPEUTIC COMPOUNDS

#60
20160108056
2016-04-21

Heterocyclic derivatives and use thereof

#61
20160075670
2016-03-17

BENZOTHIAZOLONE COMPOUND

#62
20160058745
2016-03-03

Casein kinase 1delta (CK1delta) inhibitors

#63
20160015835
2016-01-21

Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

#64
20150361097
2015-12-17

Heterocyclic amide derivatives as P2Xreceptor antagonists

#65
20150361096
2015-12-17

Heterocyclic amide derivatives as P2X7 receptor antagonists

#66
20150336914
2015-11-26

BENZOTHIAZOLONE COMPOUND

#67
20150299189
2015-10-22

Amine derivative or salt thereof

#68
20150289512
2015-10-15

METHOD FOR PROMOTING PLANT GROWTH

#69
20150209368
2015-07-30

Casein kinase 1δ (CK 1δ) inhibitors

#70
20150094346
2015-04-02

BENZOTHIAZOLONE COMPOUND

#71
20150065490
2015-03-05

ORGANIC COMPOUNDS

#72
20150031685
2015-01-29

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#73
20150018339
2015-01-15

HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS

#74
20140364601
2014-12-11

PROCESS

#75
20140364444
2014-12-11

Fused heterocyclic compound and use thereof for pest control

#76
20140329831
2014-11-06

Dopamine D3 receptor ligands and preparation and medical uses of the same

#77
20140328755
2014-11-06

Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders

#78
20140323467
2014-10-30

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#79
20140275064
2014-09-18

DYRK1 inhibitors and uses thereof

#80
20140154716
2014-06-05

LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS

#81
20140127737
2014-05-08

Variable color two-photon fluorescent probe, method for imaging thiol activation in mitochondrion using same, and method for manufacturing the variable color two-photon fluorescent probe

#82
20140093894
2014-04-03

Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

#83
20140058111
2014-02-27

Process of manufacturing benzobisthiazole building blocks for conjugated polymers

#84
20140045829
2014-02-13

Substituted 1,3-benzothiazol-2(3H)-ones and [1,3]thiazolo[5,4-B]pyridin-2(1H)-ones as positive allosteric modulators of mGluR2

#85
20130245080
2013-09-19

Benzothiazolone compound

#86
20130245008
2013-09-19

Nitrobenzothiazole derivatives, preparation thereof and therapeutic applications thereof

#87
20130231333
2013-09-05

Estrogen receptor modulators and uses thereof

#88
20130131321
2013-05-23

LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY

#89
20130130289
2013-05-23

Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

#90
20130085276
2013-04-04

Carboxylation catalysts

#91
20130040999
2013-02-14

Compounds for alleviation, prevention or treatment of osteoporosis, the preparation thereof and pharmaceutical composition comprising the same

#92
20130035332
2013-02-07

Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2

#93
20130012561
2013-01-10

Estrogen receptor modulators and uses thereof

#94
20120316162
2012-12-13

Piperidine and piperazine derivatives

#95
20120277185
2012-11-01

Pesticidal carboxamides

#96
20120276564
2012-11-01

Luciferins

#97
20120122849
2012-05-17

PKM2 modulators for use in the treatment of cancer

#98
20120108585
2012-05-03

BENZOXAZOLES, BENZTHIAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS

#99
20120071535
2012-03-22

Estrogen receptor modulators and uses thereof

#100
20120064032
2012-03-15

Hydroxamates as therapeutic agents

#101
20120046292
2012-02-23

DIACYLETHYLENEDIAMINE COMPOUND

#102
20120041041
2012-02-16

5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY

#103
20120021912
2012-01-26

Herbicidally active cyclopentanediones and derivatives thereof, and their use in controlling weeds

#104
20120004165
2012-01-05

Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments

#105
20110319423
2011-12-29

Dopamine D3 receptor ligands and preparation and medical uses of the same

#106
20110294822
2011-12-01

Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof

#107
20110280804
2011-11-17

Highly selective sigma receptor radioligands

#108
20110269756
2011-11-03

Benzothiazolone derivatives

#109
20110251200
2011-10-13

Aryl guanidine FF-ATPase inhibitors and related methods

#110
20110223625
2011-09-15

Bioluminescent assays using cyanobenzothiazole compounds

#111
20110201781
2011-08-18

CYSTEINE LABELING SYSTEM AND METHOD OF USE THEREOF

#112
20110195955
2011-08-11

Highly selective sigma receptor ligands

#113
20110172415
2011-07-14

NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP

#114
20110136156
2011-06-09

Luciferins

#115
20110112084
2011-05-12

Bicyclic androgen and progesterone receptor modulator compounds and methods

#116
20110034694
2011-02-10

Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

#117
20110021528
2011-01-27

Hydroxamates as therapeutic agents

#118
20100331307
2010-12-30

Therapeutic compounds and compositions

#119
20100329978
2010-12-30

Highly selective sigma receptor ligands

#120
20100324071
2010-12-23

Glucokinase activators and methods of using same

#121
20100317658
2010-12-16

4,7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation And Their Therapeutic Uses

#122
20100256130
2010-10-07

MORPHOLINYL AND PYRROLIDINYL ANALOGS

#123
20100234377
2010-09-16

PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE

#124
20100222341
2010-09-02

Piperidine and piperazine derivatives

#125
20100222326
2010-09-02

New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders

#126
20100216840
2010-08-26

BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS

#127
20100210688
2010-08-19

Novel Benzothiazolone Derivatives

#128
20100210630
2010-08-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#129
20100137298
2010-06-03

Biaryl Sulfonamides and Methods for Using Same

#130
20100113522
2010-05-06

Compounds for the modulation of PPARγ activity

#131
20100098634
2010-04-22

Imaging agents useful for identifying AD pathology

#132
20100093813
2010-04-15

Salts 668

#133
20100075351
2010-03-25

Bioluminescent detection of cyanohydroxy benzothiazole compounds

#134
20100069379
2010-03-18

Bicyclic androgen and progesterone receptor modulator compounds and methods

#135
20100062470
2010-03-11

Luminogenic compounds and methods to detect cytochrome P450 3A enzymes

#136
20100048893
2010-02-25

Substituted arylalkanoic acid derivatives and use thereof

#137
20100041891
2010-02-18

AMIDE COMPOUND

#138
20100016388
2010-01-21

Salts of a Selective Beta-2 Andrenoceptor Agonist

#139
20090275571
2009-11-05

Morpholinyl and pyrrolidinyl analogs

#140
20090264459
2009-10-22

Organic Compounds

#141
20090240052
2009-09-24

Anthranilic acid derivative or salt thereof

#142
20090239917
2009-09-24

Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them

#143
20090239916
2009-09-24

NOVEL DRUG DISCOVERY TARGET AND MEDICINE ACTING ON THE SAME

#144
20090221653
2009-09-03

7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists

#145
20090221635
2009-09-03

Quinolinyl and benzothiazolyl modulators

#146
20090220454
2009-09-03

Hydroxamates as therapeutic agents

#147
20090209564
2009-08-20

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

#148
20090203753
2009-08-13

7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists

#149
20090176773
2009-07-09

Non-Peptidic Inhibitors of AKAP/PKA Interaction

#150
20090170913
2009-07-02

MCH receptor antagonists

#151
20090143376
2009-06-04

Fused heterocyclic compounds and their use as sirtuin modulators

#152
20090130165
2009-05-21

MIF Inhibitors

#153
20090062530
2009-03-05

Substituted arylalkanoic acid derivatives and use thereof

#154
20090062261
2009-03-05

Nitrogen-containing heterocycle derivatives substituted with cyclic group

#155
20090062259
2009-03-05

Bezothiazol derivatives as Beta2 adrenoreceptor agonists

#156
20090048298
2009-02-19

Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

#157
20090030046
2009-01-29

Glucokinase activators and methods of using same

#158
20090023730
2009-01-22

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

#159
20080319032
2008-12-25

TETRAHYDROBENZOTHIAZOLE ANALOGUES AS NEUROPROTECTIVE AGENTS

#160
20080319031
2008-12-25

Novel Tyrosine Derivatives

#161
20080311113
2008-12-18

METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE

#162
20080306121
2008-12-11

Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds

#163
20080300275
2008-12-04

Benzothiazolone derivatives

#164
20080299593
2008-12-04

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

#165
20080280961
2008-11-13

Amino-alkyl amide derivatives as CCR3 receptor ligands

#166
20080269265
2008-10-30

Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas

#167
20080255221
2008-10-16

Hydroxamates as therapeutic agents

#168
20080255214
2008-10-16

Hydroxamates as therapeutic agents

#169
20080255196
2008-10-16

Pesticide thiazolyloxy substituted phenylamidine derivatives

#170
20080255169
2008-10-16

Sulphonamide Derivatives

#171
20080249145
2008-10-09

Pharmaceutical salts of N-[2-(diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(1-napthyl)ethoxy]propanamide

#172
20080249130
2008-10-09

Gut microsomal triglyceride transport protein inhibitors

#173
20080226557
2008-09-18

Luciferins

#174
20080171767
2008-07-17

Acetamide compounds as fungicides

#175
20080161370
2008-07-03

Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors

#176
20080139547
2008-06-12

ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE

#177
20080114041
2008-05-15

Benzothiazolesulfonamides

#178
20080108676
2008-05-08

Benzothiazolecarboxamides

#179
20080097105
2008-04-24

Compounds having βadrenergic receptor agonist and muscarinic receptor antagonist activity

#180
20080096940
2008-04-24

5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity

#181
20080096911
2008-04-24

Compounds having βadrenergic receptor agonist and muscarinic receptor antagonist activity

#182
20080070948
2008-03-20

BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS

#183
20080070927
2008-03-20

Substituted heterocyclic compounds

#184
20080021023
2008-01-24

Morpholinyl and pyrrolidinyl analogs

#185
20080009520
2008-01-10

BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS

#186
20080004331
2008-01-03

Hydroxamates as therapeutic agents

#187
20070293540
2007-12-20

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

#188
20070265309
2007-11-15

Substituted bis aryl and heteroaryl compounds as selective 5HTantagonists

#189
20070249586
2007-10-25

Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity

#190
20070244186
2007-10-18

4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses

#191
20070225327
2007-09-27

Biaryl sulfonamides and methods for using same

#192
20070219258
2007-09-20

NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME

#193
20070213333
2007-09-13

Substituted arylalkanoic acid derivatives and use thereof

#194
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#195
20070197472
2007-08-23

N-Alkynyl-2-Heteroaryloxyalkylamides For Use As Fungicides

#196
20070191447
2007-08-16

Novel heterocyclic compound

#197
20070167452
2007-07-19

Therapeutic amide derivatives

#198
20070155806
2007-07-05

Luciferin derivatives

#199
20070155726
2007-07-05

Diamine derivatives as inhibitors of leukotriene Ahydrolase

#200
20070072928
2007-03-29

Substituted propylamine derivatives and methods of their use

#201
20070049635
2007-03-01

Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients

#202
20070042996
2007-02-22

N-alkyny-2-(substituted aryloxy) alkylthioamine derivatives as fungicides

#203
20070015790
2007-01-18

Luminogenic and fluorogenic compounds and methods to detect molecules or conditions

#204
20060258707
2006-11-16

Benzimidazolidinone derivatives as muscarinic agents

#205
20060205941
2006-09-14

Histone deacetylase inhibitors

#206
20060205785
2006-09-14

Benzimidazolidinone derivatives as muscarinic agents

#207
20060199799
2006-09-07

Benzimidazolidinone derivatives as muscarinic agents

#208
20060111344
2006-05-25

Arylethanolamine β-adrenoreceptor agonist compounds

#209
20060106075
2006-05-18

Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity

#210
20060052605
2006-03-09

Substituted heterocyclic compounds

#211
20060040997
2006-02-23

Benzthiazole-3 oxides useful for the treatment of proliferative disorders

#212
20060025416
2006-02-02

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

#213
20060025402
2006-02-02

Benzimidazolidinone derivatives as muscarinic agents

#214
20060014836
2006-01-19

Substituted aryl thioureas and related compounds; inhibitors of viral replication

#215
20060014752
2006-01-19

Heterocyclic anti-epileptogenic agents and methods of use thereof

#216
20060004066
2006-01-05

Method for treating ADAMTS-5-associated disease

#217
20050288350
2005-12-29

Bicyclic androgen and progesterone receptor modulator compounds and methods

#218
20050267174
2005-12-01

Condensation reagents and a process for their preparation

#219
20050227994
2005-10-13

Decomposition inhibitor for extracellular matrix of cartilage

#220
20050215587
2005-09-29

Serine protease inhibitors

#221
20050187261
2005-08-25

Hydroxamates as therapeutic agents

#222
20050154202
2005-07-14

Substituted aryl amides

#223
20050143422
2005-06-30

Biaryl sulfonamides and methods for using same

#224
20050131018
2005-06-16

Acetylene derivatives as inhibitors of histone deacetylase

#225
20050130973
2005-06-16

Biaryl sulfonamides and methods for using same

#226
20050113417
2005-05-26

Compounds having βadrenergic receptor agonist and muscarinic receptor antagonist activity

#227
20050043379
2005-02-24

LTA4H Modulators

#228
20050043378
2005-02-24

LTA4H modulators

#229
20050043358
2005-02-24

Aminoalcohol derivatives and their use as beta 3 adrenergic agonists

#230
20050026973
2005-02-03

Heterocyclic oxime compounds

#231
20050004133
2005-01-06

Modulators of VR1 receptor